Medacta Group SA

Swiss Stock Exchange MOVE.SW

Medacta Group SA Price to Earnings Ratio (P/E) on January 14, 2025: 45.57

Medacta Group SA Price to Earnings Ratio (P/E) is 45.57 on January 14, 2025, a -15.50% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Medacta Group SA 52-week high Price to Earnings Ratio (P/E) is 59.17 on August 27, 2024, which is 29.84% above the current Price to Earnings Ratio (P/E).
Medacta Group SA 52-week low Price to Earnings Ratio (P/E) is 44.99 on December 30, 2024, which is -1.28% below the current Price to Earnings Ratio (P/E).
Medacta Group SA average Price to Earnings Ratio (P/E) for the last 52 weeks is 52.38.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Swiss Stock Exchange: MOVE.SW

Medacta Group SA

CEO	Dr. Francesco Siccardi
IPO Date	April 3, 2019
Location	Switzerland
Headquarters	Strada Regina, 34
Employees	1,826
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Key trends

Past 5 years